Agilent Technologies and Strand Life Sciences Announce GeneSpring Development Agreement

Agilent Technologies Inc. today announced an agreement in which Strand Life Sciences will develop Agilent's GeneSpring software. This move is designed to accelerate upgrades as Agilent aggressively addresses evolving customer needs. This agreement expands on an existing relationship between Stratagene Corp. and Strand. Stratagene was acquired by Agilent in June 2007.

Please to read the entire article.

You must be logged in to post a comment Login